Publications To Date


    Filter Publications

    PAGE 5 OF 221 | DISPLAYING 61 - 75 OF 3305 RESULTS

    Mouton W et al. Towards standardization of immune functional assays., , Clin Immunol., Jan 01, 2020

    Pantera H et al. Regulating PMP22 expression as a dosage sensitive neuropathy gene, , Brain Res., Jan 01, 2020

    Beechem JM et al., High-Plex Spatially Resolved RNA and Protein Detection Using Digital Spatial Profiling: A Technology Designed for Immuno-oncology Biomarker Discovery and Translational Research., , Methods Mol Biol, Jan 01, 2020

    Leong WI et al., Low-dose metronomic cyclophosphamide complements the actions of an intratumoral C-class CpG TLR9 agonist to potentiate innate immunity and drive potent T cell-mediated anti-tumor responses., , Oncotarget, Dec 31, 2019

    Linge A et al., Comparison of detection methods for HPV status as a prognostic marker for loco-regional control after radiochemotherapy in patients with HNSCC., , Radiother Oncol., Dec 30, 2019

    Nolan MW et al., Pet Dogs with Subclinical Acute Radiodermatitis Experience Widespread Somatosensory Sensitization., , Radiat Res, Dec 26, 2019

    Rozeman EA et al., Phase Ib/II trial testing combined radiofrequency ablation and ipilimumab in uveal melanoma (SECIRA-UM)., , Melanoma Res, Dec 26, 2019

    Zografos E et al., Prognostic role of microRNAs in breast cancer: A systematic review., , Oncotarget, Dec 24, 2019

    Brandão M et al., Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors., , Ann Oncol, Dec 20, 2019

    Migliavacca E et al., Mitochondrial oxidative capacity and NAD+ biosynthesis are reduced in human sarcopenia across ethnicities., , Nat Commun, Dec 20, 2019

    Kargl J et al., Neutrophil content predicts lymphocyte depletion and anti-PD1 treatment failure in NSCLC., , JCI Insight, Dec 19, 2019

    Yu J et al., Reduced H3K27me3 leads to abnormal Hox gene expression in neural tube defects., , Epigenetics Chromatin, Dec 19, 2019

    Ahern E et al., Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN)., , Trials, Dec 19, 2019

    Denker S et al., A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response., , Int J Hematol Oncol, Dec 19, 2019

    Cristino AS et al., EBV-microRNA-BHRF1-2-5p targets the 3'UTR of immune-checkpoint ligands PD-L1 and PD-L2, , Blood, Dec 19, 2019